Vimarsana
Biggest News Aggregation in the World

Page 3 - Drug Processing Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drug Processing Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drug Processing Technology Today - Breaking & Trending Today

Corcept terminates Phase III pancreatic ductal adenocarcinoma trial - Vimarsana News

Corcept terminates Phase III pancreatic ductal adenocarcinoma trial

Apart from pancreatic ductal adenocarcinoma, studies in liver disease, venous leg ulcer, sleep apnoea, and ocular issues are also reviewed.

Parkinson's disease: Cerevance outlines Phase II/III trial planned for 2023 - Vimarsana News

Parkinson's disease: Cerevance outlines Phase II/III trial planned for 2023

Cerevance CMO Jordan Dubow shares exclusive details on the first of two planned registrational trials in Parkinson’s disease.

Dengue fever: the urgent hunt for antivirals and vaccines - Vimarsana News

Dengue fever: the urgent hunt for antivirals and vaccines

There are 100–400 million Dengue fever infections each year, and cases are quickly rising. How can manufacturers develop reliable antivirals and vaccines?

Biogen caves in on Aduhelm: how biotechs can avoid the same mistakes - Vimarsana News

Biogen caves in on Aduhelm: how biotechs can avoid the same mistakes

After Biogen all but waved the white flag on its once-promising Aduhelm, Clinical Trials Arena explores how drug developers can dodge a similar fate.

Transcenta doses first subject in Phase I osteoporosis drug trial in China - Vimarsana News

Transcenta doses first subject in Phase I osteoporosis drug trial in China

Transcenta has dosed the first subject in the Phase I trial of its drug candidate, TST002 (Blosozumab), to treat osteoporosis in China.